ClinicalTrials.govpublic full text
Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children
acute lymphoblastic leukemia, pediatric, acute lymphoblastic leukemia, in relapse, refractory acute lymphoblastic leukemia, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886634
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.